Michael Camilleri , M.D.
Professor of Medicine and Physiology
Mayo Clinic College of Medicine

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh Medical School

Gerald F. Gebhart, Ph.D.
Director, Pittsburgh Center for Pain Research and Professor, Anesthesiology, Pain Research, University of Pittsburgh

Steven B. Landau, M.D .
Director, Clinical and Scientific Analysis
HealthCare Ventures, LLC

J. David Leander, Ph.D.
President
Skagit Neuropharm Consulting

Michael Camilleri, M.D.
Professor of Medicine and Physiology
Mayo Clinic College of Medicine

Dr. Camilleri is professor of medicine and physiology in the Mayo Clinic College of Medicine. He received his undergraduate training and medical degree from his native Malta in 1975, and pursued academic and clinical training at Hammersmith Hospital and the Royal Postgraduate Medical School in London. His research training led to a Masters degree from the University of London, and he was elected to the Fellowship of the Royal Colleges of Physicians of London and Edinburgh. Dr. Camilleri joined the staff of the Mayo Clinic in 1987. In 2001, he was named the Atherton and Winifred W. Bean Professor at the Mayo Clinic College of Medicine. Dr. Camilleri served on the Governing Board of the American Neurogastroenterology and Motility Society (ANMS) from 1996 to 2000, and as Chair of the Clinical Practice Section of the ANMS from 1997 to 1998, and is currently President-elect of the ANMS. Dr. Camilleri is the first or senior author of over 300 articles, and has co-authored three books. He has served on the editorial boards of such journals as: Gastroenterology, Clinical Gastroenterology and Hepatology, and Neurogastroenterology and Motility. Dr. Camilleri has a long list of awards, including the Mayo Clinic Department of Internal Medicine’s Outstanding Investigator Award, Outstanding Mentor Award, the Janssen Research Foundation Clinical Research Award, and the Functional Brain-Gut Research Scientist Award.

William C. de Groat, Ph.D.
Professor of Pharmacology
University of Pittsburgh Medical School

Dr. de Groat is professor of pharmacology at the University of Pittsburgh Medical School. He received a Ph.D. in pharmacology at the University of Pennsylvania Medical School. Dr. de Groat obtained postdoctoral training in pharmacology at the University of Pennsylvania and in Neurophysiology at the John Curtin School for Medical Research in Canberra, Australia. He joined the faculty at the University of Pittsburgh in 1968. He has been a visiting scientist at the National Institutes of Health and a visiting professor at the University College London. Dr. de Groat is a member of various societies and he has served on numerous editorial boards of such journals as: Journal of Pharmacology and Experimental Therapeutics, American Journal of Physiology, Urology, Neurourology and Urodynamics, Autonomic Neuroscience, Life Sciences and Current Opinion in Central and Peripheral Nervous System Investigational Drugs. He has been treasurer and a member of the Executive Council of the Society for Neuroscience and the executive vice president of the International Society for Autonomic Neuroscience. Dr. de Groat has a long list of awards, including an NIH MERIT Award, as well as catalog of over 300 published papers in the fields of autonomic neuroscience and neurourology.

Gerald F. Gebhart, Ph.D.
Director, Pittsburgh Center for Pain Research and Professor, Anesthesiology, Pain Research, University of Pittsburgh

Dr. Gebhart is Director of the newly established Pittsburgh Center for Pain Research and Professor, Anesthesiology, Pain Research at the University of Pittsburgh. Previously, Dr. Gebhart was professor and head, Department of Pharmacology, the University of Iowa. He earned his Ph.D. in pharmacology from the University of Iowa. After two years of study at the Universite de Montreal, Dr. Gebhart joined the faculty in the Department of Pharmacology at the University of Iowa as an assistant professor and was promoted to associate professor and then to professor. Dr. Gebhart’s research has focused on mechanisms and modulation of pain. Dr. Gebhart received a five-year Bristol Myers Award for Excellence in Pain Research, a Method to Extend Research in Time (MERIT) Award from the National Institutes of Health (NIH), the Frederick W.L. Kerr Award from the American Pain Society, the Kappa Delta Elizabeth Winston-Lanier Award from the American Academy of Orthopedic Surgeons, the John J. Bonica Award from the American Society for Regional Anesthesia, and the Distinguished Service Award from the American Pain Society. Dr. Gebhart is editor-in-chief of The Journal of Pain, chair of the Editorial Board of the book series Pain Research and Clinical Management, has published more than 250 peer-reviewed papers, and has served on national research advisory committees, editorial boards, and committees of international scientific organizations.

Steven B. Landau , M.D.
Director, Clinical and Scientific Analysis
HealthCare Ventures, LLC

Dr. Landau is director of clinical and scientific analysis at Healthcare Ventures, LLC, a leading venture capital firm specializing in life science investing. Dr. Landau is a summa cum laude graduate of Bowdoin College. He earned his M.D. from Case Western Reserve University in Cleveland Ohio. Dr. Landau completed his post graduate training at the Beth Israel Hospital and the Brigham and Women’s Hospital in Boston. He is board certified in medicine and gastroenterology. Dr. Landau has been in the biotechnology field for over 10 years. He has been associated with OraVax, LeukoSite, Inc., Millennium Pharmaceuticals, Inc., (by merger), Praecis Pharmaceuticals, Inc. and Dynogen Pharmaceuticals Inc. During his tenure at LeukoSite and Millennium Pharmaceuticals, Dr. Landau directed a successful Phase 2 program in inflammatory bowel diseases among other responsibilities. He has established new clinical programs in the areas of gastroenterology, metabolism, inflammation and central nervous system disorders. Immediately prior to joining Healthcare Ventures, Dr. Landau was at Dynogen Pharmaceuticals where he was initially vice president of clinical development and subsequently was appointed senior vice president of strategic corporate development.

J. David Leander, Ph.D.
President
Skagit Neuropharm Consulting

Dr. Leander is the founder of Skagit Neuropharm Consulting and consults on neuropharmacology and neuropharmaceuticals for biotech companies and venture capital groups. Before founding Skagit Neuropharm Consulting, Dr. Leander spent over 21 years at Eli Lilly and Company in the neuroscience discovery area. Throughout his career at Lilly, Dr. Leander worked closely with various groups charged with business development and research acquisition resulting in numerous in- and out-licensing activities being pursued and consummated. For about eight years of his Lilly career, Dr. Leander served as the neuroscience discovery liaison to the Neuroscience Development Strategy Group at Eli Lilly KK in Kobe, Japan. Dr. Leander also worked with Elanco Animal Health, a Division of Eli Lilly and Company, in leveraging assets from the Neuroscience Discovery area into potential products targeted for companion animals.

Prior to joining Lilly, Dr. Leander was an associate professor of pharmacology and psychology at the University of North Carolina. Dr. Leander received his Ph.D. in neurobiology and experimental psychology, at the University of Florida, an M.B.A. in management from Indiana University School of Business, an M.A. from Western Washington State University, and his B.A. from Pacific Lutheran University. Dr. Leander is an author on more than 200 scientific papers in various areas of neuropharmacology.